"10.1371_journal.pone.0076206","plos one","2013-10-01T00:00:00Z","David A White; Lu Fang; William Chan; Eric F Morand; Helen Kiriazis; Stephen J Duffy; Andrew J Taylor; Anthony M Dart; Xiao-Jun Du; Xiao-Ming Gao","Baker IDI Heart and Diabetes Institute, Melbourne, Australia; Department of Cardiovascular Medicine, Alfred Hospital, Melbourne, Australia; Centre for Inflammatory Diseases, Monash University, Melbourne, Australia; Department of Medicine, Central Clinical School, Monash University, Melbourne, Australia; Department of Surgery, Central Clinical School, Monash University, Melbourne, Australia","Conceived and designed the experiments: XMG XJD AMD. Performed the experiments: XMG DAW LF WC HK SJD AJT. Analyzed the data: XMG DAW LF WC HK SJD AJT. Contributed reagents/materials/analysis tools: EFM SJD AJT. Wrote the manuscript: XMG DAW XJD.","The authors have the following interests. The authors declare that although Cortical pharmaceutical company donated the anti-MIF compound, COR100140, it did not influence any part of this research. This study was partly funded by a postgraduate scholarship from GlaxoSmithKline Australia to WC. There are no further patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2013","10","David A White","DAW",10,TRUE,3,7,7,3,TRUE,TRUE,FALSE,0,NA,FALSE
